Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Farmers Insurance
UBS
Chubb
Chinese Patent Office
AstraZeneca

Generated: May 22, 2019

DrugPatentWatch Database Preview

West-ward Pharms Int Company Profile

« Back to Dashboard

What is the competitive landscape for WEST-WARD PHARMS INT, and what generic and branded alternatives to WEST-WARD PHARMS INT drugs are available?

WEST-WARD PHARMS INT has three hundred and sixty-two approved drugs.

There is one tentative approval on WEST-WARD PHARMS INT drugs.

Summary for West-ward Pharms Int
US Patents:0
Tradenames:237
Ingredients:212
NDAs:362

Drugs and US Patents for West-ward Pharms Int

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int GENTAMICIN SULFATE gentamicin sulfate INJECTABLE;INJECTION 062251-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
West-ward Pharms Int GANCICLOVIR SODIUM ganciclovir sodium INJECTABLE;INJECTION 076222-001 Jul 16, 2003 DISCN No No ➤ Sign Up ➤ Sign Up
West-ward Pharms Int DURAMORPH PF morphine sulfate INJECTABLE;INJECTION 018565-001 Sep 18, 1984 AP RX Yes Yes ➤ Sign Up ➤ Sign Up
West-ward Pharms Int LEUCOVORIN CALCIUM leucovorin calcium TABLET;ORAL 072734-001 Feb 22, 1993 RX No No ➤ Sign Up ➤ Sign Up
West-ward Pharms Int NALOXONE naloxone hydrochloride INJECTABLE;INJECTION 070299-001 Sep 24, 1986 AP RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Expired US Patents for West-ward Pharms Int

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
West-ward Pharms Int FACTREL gonadorelin hydrochloride INJECTABLE;INJECTION 018123-003 Sep 30, 1982 3,947,569 ➤ Sign Up
West-ward Pharms Int FACTREL gonadorelin hydrochloride INJECTABLE;INJECTION 018123-001 Sep 30, 1982 3,947,569 ➤ Sign Up
West-ward Pharms Int ATIVAN lorazepam INJECTABLE;INJECTION 018140-001 Approved Prior to Jan 1, 1982 4,017,616 ➤ Sign Up
West-ward Pharms Int FACTREL gonadorelin hydrochloride INJECTABLE;INJECTION 018123-002 Sep 30, 1982 4,110,438 ➤ Sign Up
West-ward Pharms Int FACTREL gonadorelin hydrochloride INJECTABLE;INJECTION 018123-002 Sep 30, 1982 3,947,569 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for WEST-WARD PHARMS INT drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 1 mg ➤ Subscribe 2009-08-14
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Queensland Health
Deloitte
Healthtrust
Johnson and Johnson
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.